Calidi Biotherapeutics reported net income of -$4.16M for the quarter ended Jun 2026. This income statement covers 18 quarters of results from Dec 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating items | ||||||||||||||||||
| Depreciation & Amortization - TotalDep. & Amort. (Tot) | 0.10M | 0.10M | 0.10M | 0.10M | 0.10M | 0.09M | 0.09M | |||||||||||
| Research & DevelopmentR&D | 1.95M | 2.26M | 2.62M | 3.18M | 3.25M | 3.96M | 2.74M | 2.17M | 2.15M | 1.81M | 2.42M | 2.59M | 2.36M | 2.36M | 2.56M | |||
| Selling, General & AdministrativeSG&A | 5.04M | 2.42M | 2.79M | 3.36M | 3.97M | 5.86M | 4.01M | 3.60M | 3.07M | 2.21M | 2.64M | 3.07M | 2.69M | 2.11M | 1.59M | |||
| Other Operating ExpensesOther Opex | 0.53M | 0.36M | -0.10M | -0.10M | -0.10M | -0.10M | -0.10M | -0.09M | -0.09M | |||||||||
| Operating ExpensesOpex | 0.53M | 0.36M | 6.99M | 4.69M | 5.41M | 6.54M | 7.22M | 9.82M | 6.75M | 5.77M | 5.23M | 4.03M | 5.06M | 5.66M | 5.05M | 4.47M | 4.15M | |
| Operating IncomeOp. Inc | -0.53M | -0.36M | -6.99M | -4.69M | -5.41M | -6.54M | -7.22M | -9.82M | -6.75M | -5.77M | -5.23M | -4.03M | -5.06M | -5.66M | -5.05M | -4.47M | -4.15M | |
| EBIT | -0.53M | -0.36M | -6.99M | -4.69M | -5.41M | -6.54M | -7.22M | -9.82M | -6.75M | -5.77M | -5.23M | -4.03M | -5.06M | -5.66M | -5.05M | -4.47M | -4.15M | |
| Non-operating items | ||||||||||||||||||
| Non Operating Interest Expenses | 0.03M | 0.10M | 0.20M | 0.21M | 0.30M | 0.30M | 0.30M | 0.17M | 0.13M | 0.11M | 0.04M | 0.03M | 0.03M | 0.04M | 0.03M | |||
| Non Operating Investment IncomeNon-Op. Investment Inc. | 0.00M | 0.03M | 0.01M | |||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.02M | 0.16M | 1.09M | |||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | 0.00M | -0.01M | -0.01M | -0.02M | -0.01M | -0.02M | -0.02M | 0.01M | 0.01M | 0.01M | -0.01M | -0.02M | 0.02M | 0.31M | 0.03M | |||
| Non Operating IncomeNon Op. Inc. | 1.99M | 4.52M | 1.63M | -3.07M | -1.04M | -5.96M | 5.21M | 1.59M | -0.47M | 0.01M | 0.16M | -0.12M | 0.00M | -0.09M | -0.12M | 0.41M | -0.01M | |
| Net income details | ||||||||||||||||||
| EBT | 1.46M | 4.16M | -5.35M | -7.76M | -6.46M | -12.50M | -2.01M | -8.23M | -7.22M | -5.76M | -5.07M | -4.14M | -5.06M | -5.76M | -5.17M | -4.06M | -4.16M | |
| Tax ProvisionsTaxes | 0.00M | -0.00M | 0.00M | 0.00M | 0.01M | -0.00M | 0.00M | 0.01M | -0.00M | 0.00M | 0.00M | 0.00M | 0.01M | -4.23M | 0.01M | |||
| Profit After TaxPAT | -7.74M | -4.58M | -5.36M | -7.76M | -6.46M | -12.50M | -2.02M | -8.23M | -7.22M | -5.77M | -5.07M | -4.15M | -5.06M | -5.76M | -5.18M | -4.06M | -4.16M | |
| Income from Non-Controlling InterestsInc. Minority | -0.01M | -0.05M | -0.08M | -0.05M | -0.03M | -0.19M | ||||||||||||
| Income from Continuing OperationsIncome (Continuing) | 1.46M | 4.16M | -5.36M | -7.76M | -6.46M | -12.50M | -2.02M | -8.23M | -7.22M | -5.77M | -5.07M | -4.15M | -5.06M | -5.76M | -5.18M | 0.17M | -4.16M | |
| Consolidated Net IncomeConsol Net Inc. | 1.46M | 4.16M | -5.36M | -7.76M | -6.46M | -12.50M | -2.02M | -8.23M | -7.22M | -5.77M | -5.07M | -4.15M | -5.06M | -5.76M | -5.18M | 0.17M | -4.16M | |
| Income towards Parent CompanyParent Net Inc | 1.46M | 4.16M | -5.36M | -7.76M | -6.46M | -12.50M | -2.02M | -8.23M | -7.22M | -5.77M | -5.07M | -4.15M | -5.06M | -5.76M | -5.18M | 0.17M | -4.16M | |
| Net Income towards Common StockholdersNet Income | 1.46M | 4.16M | -5.36M | -7.76M | -6.46M | -12.50M | -2.02M | -8.23M | -7.22M | -7.44M | -5.05M | -4.10M | -4.99M | -5.71M | -10.82M | -4.06M | -4.16M | |
| Additional items | ||||||||||||||||||
| EPS (Basic) | 122.06 | 347.38 | -495.65 | -842.59 | -628.05 | -0.00M | -271.57 | -935.65 | -390.22 | -268.05 | -124.03 | -98.27 | -35.34 | -31.78 | -35.29 | -15.09 | -2.94 | |
| EPS (Diluted) | 122.06 | 347.38 | -495.65 | -842.59 | -628.05 | -0.00M | -271.57 | -935.65 | -390.22 | -268.05 | -124.03 | -98.27 | -35.34 | -31.78 | -35.29 | -15.09 | -2.94 | |
| Shares Outstanding | 0.00M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.00M | 0.01M | 0.01M | 0.02M | 0.03M | 0.04M | 0.04M | 0.14M | 0.18M | 0.31M | 0.27M | 1.42M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.00M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.02M | 0.03M | 0.04M | 0.04M | 0.14M | 0.18M | 0.31M | 0.27M | 1.42M |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 0.02M | 0.03M | 0.03M | 0.02M | 0.02M | 0.01M | 0.01M | 0.01M | 0.01M | 0.02M | 0.03M | 0.05M | 0.04M | 0.17M | 0.18M | 0.31M | 0.27M | 1.42M |
| EBITDA | -0.53M | -0.36M | -6.99M | -4.69M | -5.41M | -6.54M | -7.22M | -9.82M | -6.75M | -5.67M | -5.13M | -3.93M | -5.06M | -5.57M | -4.94M | -4.37M | -4.06M | |
| Interest ExpensesInt Expense | 0.03M | 0.10M | 0.20M | 0.21M | 0.30M | 0.30M | 0.30M | 0.17M | 0.13M | 0.11M | 0.04M | 0.03M | 0.03M | 0.04M | 0.03M | |||
| Tax Rate | -0.02% | 0.04% | -0.06% | -0.03% | -0.55% | 0.04% | -0.06% | -0.14% | 0.02% | -0.07% | -0.06% | -0.07% | -0.19% | 104.09% | -0.12% |